Skip to main content
    S

    Soligenix Inc. (SNGX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.32
    +0.00 (+0.31%)

    Market Cap: $7.50M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Soligenix Inc. (SNGX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2026. Financial statements from company filings, amounts in US dollars.

    Soligenix reported revenue of $0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was -$11.08M, operating cash flow was -$10.27M and free cash flow was -$10.27M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$1.12M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $11.85M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0-100.0%N/AN/AN/A
    Dec 2024$119.37K-85.8%0.0%-7907.7%-6925.1%
    Dec 2023$839.36K-11.5%11.6%-917.1%-731.6%
    Dec 2022$948.91K+15.1%42.0%-1500.6%-1454.1%
    Dec 2021$824.27K-65.1%11.6%-1589.2%-1522.7%
    Dec 2020$2.36M-49.0%22.8%-787.7%-749.7%
    Dec 2019$4.63M-11.7%22.9%-227.7%-413.5%
    Dec 2018$5.24M-3.5%12.3%-172.8%-169.8%
    Dec 2017$5.43M-48.0%20.7%-139.8%-131.6%
    Dec 2016$10.45MN/A19.3%-54.6%-31.1%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$119.37K$839.36K$948.91K$824.27K$2.36M$4.63M$5.24M$5.43M$10.45M
    Cost of revenue$0$119.37K$742.05K$550.82K$728.64K$1.82M$3.57M$4.60M$4.31M$8.43M
    Gross profit$0$0$97.31K$398.09K$95.63K$538.50K$1.06M$643.73K$1.12M$2.02M
    Research and development$7.49M$5.22M$3.31M$7.94M$8.19M$9.70M$8.12M$6.75M$5.51M$4.30M
    Operating income-$11.85M-$9.44M-$7.70M-$14.24M-$13.10M-$18.59M-$10.54M-$9.06M-$7.59M-$5.71M
    Net income-$11.08M-$8.27M-$6.14M-$13.80M-$12.55M-$17.69M-$19.14M-$8.90M-$7.15M-$3.25M
    EBITDAN/A-$8.88M-$7.45M-$14.06M-$12.86M-$18.55MN/A-$9.01M-$7.50M-$3.68M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$6.35K$0$2.34K$117.03K$244.81K
    Gross profit$0$0$0-$1.00K$0$0$0$3.18K$0$0$0$23.27K
    Operating income-$1.38M-$2.10M-$2.88M-$3.19M-$2.58M-$2.76M-$3.03M-$3.71M-$1.87M-$1.74M-$2.12M-$2.14M
    Net income-$1.12M-$1.99M-$2.82M-$2.61M-$2.53M-$2.70M-$2.95M-$2.99M-$1.72M-$1.64M-$1.92M-$1.82M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $114.02K by $7.82M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$9.24M$8.97M$9.80M$14.28M$26.87M$19.89M$7.78M$10.49M$9.55M$10.27M
    Current assets$8.85M$8.83M$9.51M$13.85M$26.57M$19.47M$7.49M$10.34M$9.42M$10.11M
    Cash and equivalents$7.94M$7.82M$8.45M$13.36M$26.04M$18.68M$5.42M$8.98M$7.81M$8.77M
    Total liabilities$3.94M$4.85M$7.27M$16.75M$16.15M$16.15M$6.32M$4.21M$3.23M$2.87M
    Short-term debt$114.02K$1.37M$2.25M$9.90M$0$324.98K$0N/AN/A$0
    Long-term debtN/AN/A$1.01M$0$9.86M$9.95M$0N/A$0$0
    Shareholder equity$5.29M$4.12M$2.52M-$2.47M$10.72M$3.74M$1.46M$6.28M$6.32M$7.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$9.46M$10.50M$6.92M$9.24M$11.29M$5.76M$7.75M$8.97M$10.48M$9.87M$8.06M$9.80M
    Total liabilities$3.21M$3.85M$3.83M$3.94M$3.70M$3.93M$4.13M$4.85M$4.54M$6.40M$7.29M$7.27M
    Cash and equivalents$9.02M$9.81M$6.03M$7.94M$10.53M$5.10M$7.30M$7.82M$9.84M$9.41M$7.09M$8.45M
    Shareholder equity$6.26M$6.65M$3.09M$5.29M$7.60M$1.83M$3.61M$4.12M$5.94M$3.46M$768.37K$2.52M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$10.27M-$8.40M-$8.60M-$12.65M-$11.74M-$11.45M-$7.51M-$7.24M-$6.51M-$4.98M
    Capital expenditures$5.88K$0$1$13.07K$11.79K$7.15K$30.21K$1.93K$26.35K$7.16K
    Free cash flow-$10.27M-$8.40M-$8.60M-$12.66M-$11.75M-$11.46M-$7.54M-$7.25M-$6.54M-$4.99M
    Dividends paidN/AN/AN/A$43N/AN/AN/AN/A$0$0
    Share repurchases$708.24K$753.40K$927.07K$2.53KN/AN/AN/A$251.89K$507.54K$809.28K
    Investing cash flow-$5.88K$0$0-$13.07K-$11.79K-$7.15K-$24.71K-$925-$26.35K-$7.16K
    Financing cash flow$10.39M$7.76M$3.66M$76.82K$19.06M$24.68M$4.01M$8.42M$5.57M$8.84M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.42M-$1.71M-$2.36M-$2.75M-$2.93M-$2.74M-$1.85M-$2.23M-$2.91M-$1.92M-$1.34M-$1.83M
    Capital expendituresN/AN/A$3$1.96K$608$3.32K$0$3$0$3$0$0
    Free cash flowN/AN/A-$2.36M-$2.75M-$2.93M-$2.75M-$1.85M-$2.23M-$2.91M-$1.92M-$1.34M-$1.83M
    Last 12 quarters

    Frequently Asked Questions About SNGX

    What is Soligenix's annual revenue?

    Soligenix reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    How fast is Soligenix's revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Soligenix profitable?

    No. Soligenix reported net income of -$11.08M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does SNGX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$10.27M minus capital expenditures of $5.88K produced free cash flow of -$10.27M.

    How much debt does Soligenix have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $114.02K and cash and equivalents of $7.94M.